tradingkey.logo

Structure Therapeutics Inc <GPCR.OQ> expected to post a loss of 23 cents a share - Earnings Preview

ReutersMay 5, 2025 9:26 PM
  • Structure Therapeutics Inc GPCR.OQ GPCR.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Structure Therapeutics Inc is for a loss of 23 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Structure Therapeutics Inc is $79.50​, above​ its last closing price of $27.55. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.23

-0.22

-0.69

Missed

-208.3

Sep. 30 2024

-0.17

-0.19

-0.60

Missed

-222.8

Jun. 30 2024

-0.22

-0.23

-0.54

Missed

-137.9​

Mar. 31 2024

-0.21

-0.21

-0.57

Missed

-170.5

​​Dec. 31 2023

-0.21

-0.21

-0.66

Missed

-217.3

Sep. 30 2023

-0.37

-0.29

-0.62

Missed

-112.9​

Jun. 30 2023

-0.20

-0.28

-0.60

Missed

-116.3

Mar. 31 2023

-0.41

-0.41

-0.25

Beat

39.5

This summary was machine generated May 5 at 21:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI